# Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State.

> PubMed lists PMID 38923284 in Clinical pharmacology in drug development as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-06-24 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-38923284-teriparatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38923284-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-38923284-teriparatide-v1.json
- Content SHA-256: `14e7ff0513700e6f9381590be6f632d28d828261c94f6e65c1c4a7ab8743d04d`

## Claims and source pins

### Headline

Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State. ([`pubmed-observation-pmid-38923284-2026-07-01-88f56341ed12`](#source-pubmed-observation-pmid-38923284-2026-07-01-88f56341ed12))

### Summary

PubMed lists PMID 38923284 in Clinical pharmacology in drug development as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-06-24 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38923284-2026-07-01-88f56341ed12`](#source-pubmed-observation-pmid-38923284-2026-07-01-88f56341ed12))

### Paragraph 1

PubMed lists PMID 38923284 in Clinical pharmacology in drug development as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-06-24 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38923284-2026-07-01-88f56341ed12`](#source-pubmed-observation-pmid-38923284-2026-07-01-88f56341ed12))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38923284-2026-07-01-88f56341ed12`](#source-pubmed-observation-pmid-38923284-2026-07-01-88f56341ed12))

## Sources

<a id="source-pubmed-observation-pmid-38923284-2026-07-01-88f56341ed12"></a>
- **Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State. · retained source version 1:2026-07-01:current:88f56341ed1294272ab32ea3a3c258c536254fbf533ba6ec400eef7b447f7b77** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38923284/) (`pubmed-observation-pmid-38923284-2026-07-01-88f56341ed12`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-38923284-teriparatide-v1.json SHA-256: 14e7ff0513700e6f9381590be6f632d28d828261c94f6e65c1c4a7ab8743d04d.